Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 21, 2020; 26(43): 6822-6836
Published online Nov 21, 2020. doi: 10.3748/wjg.v26.i43.6822
Published online Nov 21, 2020. doi: 10.3748/wjg.v26.i43.6822
Table 1 Categories used to classify ampullary adenocarcinomas
| Pure histological classification | Basal histological classification | Molecular and histological classification | |
| AACs | 5 Categories | 4 Categories | 3 Categories |
| Tubular | Pure INT | Pure INT | INT |
| Mixed INT-predominant | Mixed | ||
| Mixed PB-predominant | PB | ||
| Pure PB | Pure PB | ||
| Non-tubular | Other | Other | Other |
Table 2 Immunophenotypical characterization of ampullary adenocarcinomas
| Ref. | Markers | Number | ||||||
| CK7 | CK17 | CK20 | CDX2 | MUC1 | MUC2 | |||
| Chang et al[11], 2013 | X | X | 2 | |||||
| Kumari et al[22], 2013 | X | X | X | X | X | X | 6 | |
| Ang et al[18], 2014 | X | X | X | X | 4 | |||
| Fernández Moro et al[16], 2016 | X | X | 2 | |||||
| Reid et al[15], 2016 | 0 | |||||||
| Liu et al[24], 2019 | X | X | X | X | X | X | 6 | |
| Moekotte et al[31], 2018 | X | X | X | X | 4 | |||
| Al Abbas et al[30], 2019 | X | X | X | X | 4 | |||
| Abraham et al[17], 2020 | X | X | 2 | |||||
| Total | 33% | 22% | 67% | 78% | 78% | 56% | Mean | 3.33 |
Table 3 Patient characteristics
| Patient characteristics | n |
| Age, mean ± SD (yr) | 72.9 ± 8.1 |
| M/F | 11/10 |
| BMI, mean ± SD (kg/m2) | 22.9 ± 3.9 |
| ASA I, n (%) | 3 (14.2) |
| ASA II, n (%) | 6 (28.6) |
| ASA III, n (%) | 11 (52.4) |
| ASA IV, n (%) | 1 (4.8) |
| Comorbidity, n (%) | 16 (76.1) |
| Cardiovascular disease, n (%) | 6 (28.6) |
| COPD, n (%) | 6 (28.6) |
| Hypertension, n (%) | 10 (47.6) |
| Diabetes mellitus, n (%) | 3 (14.2) |
| Symptomatic, n (%) | 12 (57.1) |
| Jaundice, n (%) | 7 (58.3) |
| Pain, n (%) | 3 (25.1) |
| Nausea or Vomiting, n (%) | 1 (8.3) |
| Loss of weight, n (%) | 1 (8.3) |
| Placement of PTBD or biliary endoprothesis, n (%) | 4 (33.3) |
| CA 19.9, mean ± SD (U/mL) | 37.1 ± 53.2 |
| Neoadjuvant therapy, n (%) | 0 (0) |
Table 4 Post-operative data
| LOS, mean ± SD (d) | 15.4 ± 6.2 |
| Overall complications, n (%) | 7 (33.3) |
| Clavien-Dindo > III, n (%) | 3 (14.2) |
| Reoperation, n (%) | 2 (9.5) |
| 30-d mortality, n (%) | 0 (0) |
- Citation: Palmeri M, Funel N, Di Franco G, Furbetta N, Gianardi D, Guadagni S, Bianchini M, Pollina LE, Ricci C, Del Chiaro M, Di Candio G, Morelli L. Tissue microarray-chip featuring computerized immunophenotypical characterization more accurately subtypes ampullary adenocarcinoma than routine histology. World J Gastroenterol 2020; 26(43): 6822-6836
- URL: https://www.wjgnet.com/1007-9327/full/v26/i43/6822.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i43.6822
